Vetoquinol acquires Canadian rights to Profender®
"The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment" - Matthieu Frenchin, CEO of Vetoquinol.
Animal health company Vetoquinol has announced the acquisition of the Canadian rights to the Profender® product family from Elanco Animal Health.
The move follows the firm's acquisition of Profender® and Drontal® product families, in relation to Elanco's 2020 acquisition of Bayer Animal Health. In January 2021, Vetoquinol also acquired the Profender® and Drontal® product families in Australia.
Commenting on the acquisition, Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire Profender® for the Canadian market, one of our prominent strategic countries.
“The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment. Adding this essential to our product portfolio in Canada will strengthen our market share in the pet segment in this strategic country.”
The Profender® family of products encompasses a range of spot-on solutions for cats.
FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.
